Cronos Group Financial Statements
NASDAQ: CRONHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cronos Group revenue and earnings
In fiscal 2025, Cronos Group generated $146.6 million in revenue, up 24.6% from fiscal 2024, its 8th consecutive year of revenue growth. Cronos Group reported a net loss of $9.4 million, compared with net income of $41.1 million a year earlier. Gross margin was 42.8% (up from 21.4%) and operating margin -11.9%.
Diluted earnings per share came in at -$0.02, down from $0.11. Over the last 5 fiscal years, CRON's revenue has grown at a 25.7% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Cronos Group income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 146.59M | 117.61M | 87.24M | 86.75M | 64.56M | 46.72M | 23.75M | 12.12M | 3.15M |
| Revenue growth (YoY) | +24.63% | +34.82% | +0.57% | +34.37% | +38.19% | +96.71% | +95.94% | +285.16% | — |
| Gross Profit | 62.76M | 25.20M | 11.91M | 15.44M | -17.59M | -25.83M | -17.60M | 6.21M | 1.57M |
| Operating Expenses | 80.15M | 101.73M | 96.71M | 126.86M | 274.38M | 193.55M | 135.72M | 26.66M | 7.70M |
| Research & Development | 4.45M | 4.23M | 5.84M | 13.13M | 21.84M | 20.37M | 12.15M | 1.81M | 0 |
| Selling, General & Admin | 63.76M | 68.12M | 72.18M | 85.72M | 111.84M | 114.95M | 104.53M | 15.89M | 5.35M |
| Operating Income | -17.39M | -76.53M | -84.80M | -111.43M | -291.97M | -219.39M | -153.32M | -20.45M | -6.12M |
| Interest Expense | — | — | — | 13.00K | 27.00K | 186.00K | 1.24M | 139.00K | 101.00K |
| Other Income (Expense) | 275.00K | 113.11M | 11.13M | -9.57M | 163.46M | 146.11M | 1.32B | -478.00K | 3.78M |
| Pretax Income | -17.12M | 36.59M | -73.67M | -121.00M | -128.51M | -73.27M | 1.17B | -20.92M | -2.35M |
| Income Tax | -14.19M | -3.44M | -3.23M | 34.17M | -431.00K | 1.35M | 0 | 0 | -862.00K |
| Net Income | -9.45M | 41.08M | -73.96M | -168.73M | -396.11M | -73.14M | 1.17B | -21.64M | -1.48M |
| Net Income growth (YoY) | -123.00% | — | — | — | — | -106.27% | — | — | — |
| EPS (Basic) | -0.02 | 0.11 | -0.19 | -0.45 | -1.07 | -0.21 | 3.76 | -0.12 | -0.01 |
| EPS (Diluted) | -0.02 | 0.11 | -0.19 | -0.45 | -1.07 | -0.21 | 3.33 | -0.12 | -0.01 |
| Shares Outstanding (Basic) | 383.47M | 382.06M | 380.96M | 376.96M | 370.39M | 351.58M | 310.07M | 172.27M | 134.80M |
| Shares Outstanding (Diluted) | 383.47M | 385.56M | 380.96M | 376.96M | 370.39M | 351.58M | 342.81M | 172.27M | 176.79M |
| EBITDA | -3.16M | -67.19M | -76.69M | -98.31M | -276.57M | -212.34M | -149.04M | -18.51M | -5.35M |
| Gross Margin | 42.81% | 21.42% | 13.65% | 17.79% | -27.25% | -55.29% | -74.09% | 51.26% | 50.02% |
| Operating Margin | -11.87% | -65.07% | -97.20% | -128.45% | -452.24% | -469.59% | -645.54% | -168.67% | -194.50% |
| Net Margin | -6.44% | 34.93% | -84.78% | -194.51% | -613.54% | -156.55% | 4911.60% | -178.50% | -47.12% |
This table shows 9 annual periods of Cronos Group's income statement, from FY 2025 back to FY 2017, across 19 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow CRON's reporting calendar. What is a income statement?